Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Incomplete course of vaccination/not received the second dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on 03 Oct 2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Incomplete course of vaccination/not received the second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 19-FEB-2025 The registered nurse mentioned If a person received their first dose of Shingrix on 03 Oct 2023 and had not received the second dose would they just need to complete the second series or would they need to restart. The health care professional reject to provide any other information. Till the time of reporting, the patients did not receive second dose of Shingrix, which led to incomplete course of vaccination.